Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: I Have Been Saying It For a While

I Have Been Saying It For a While 30 Dec 2016 13:34 #8370

  • rodney.strongg
  • rodney.strongg's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1245
  • Thank you received: 18
I have been posting for quite some time that absent an imminent cash partnership that there would be a palatable financing solution until such a partnership can be completed (my guess is the latest before Q-2) Remember, breakeven cash is projected for 2018. TIME FOR BIG-LOSS, OLD-TIMERS TO AVERAGE DOWN IMO! (I already have done so big-time before the latest news).

Good luck to all.

Please Log in or Create an account to join the conversation.

I Have Been Saying It For a While 30 Dec 2016 15:13 #8372

  • rodney.strongg
  • rodney.strongg's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1245
  • Thank you received: 18
Stock manipulated again today - just look at close - watch in January, we will surpass Forgot's 1.81 and then it's clear sailing to $20 in 2017 - yes, that's only 1.33 pre-split, but it's a beginning!

Please Log in or Create an account to join the conversation.

I Have Been Saying It For a While 31 Dec 2016 08:25 #8377

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 788
  • Thank you received: 102
I think Lincoln Park Capital acts more like the chief financial backer for CYTX and Martell is their man sitting on the board of directors. Lincoln Park must have done in depth DD and B Riley is a part of the efforts.

CYTX is going solo at least for the near future, just like VCEL and many other stem cells companies.

Please Log in or Create an account to join the conversation.

I Have Been Saying It For a While 31 Dec 2016 09:16 #8378

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2737
  • Thank you received: 199
RS
$20 in 2017 a tall order imho
Since the on going increase in shares will be happening, I think market cap a better projection tool. So, with a successful p3 scleroderma result, a $200 million market cap would seem appropriate with the on going debt a mitigating factor. FDA approval $400 million, perhaps much more, depending on whats going on with the company and the perception of the street.

Please Log in or Create an account to join the conversation.

I Have Been Saying It For a While 31 Dec 2016 09:54 #8379

  • rodney.strongg
  • rodney.strongg's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1245
  • Thank you received: 18
Hedgefund, I agree that $20 in 2017 is a reach and requires that everything must fall in place on a timely basis - certainly, there can be no missteps as CYTX has tended to have in the past - I am very confident although I can understand why most old-timers will continue to be skeptical.

Have a Happy New Year!

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.214 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites